GIUDICE, GIULIA CLAIRE
 Distribuzione geografica
Continente #
EU - Europa 108
AS - Asia 73
NA - Nord America 64
AF - Africa 2
SA - Sud America 1
Totale 248
Nazione #
US - Stati Uniti d'America 64
IT - Italia 57
SG - Singapore 45
CN - Cina 22
IE - Irlanda 18
DE - Germania 8
FI - Finlandia 8
SE - Svezia 5
AT - Austria 4
IN - India 4
CH - Svizzera 3
PT - Portogallo 2
CI - Costa d'Avorio 1
EG - Egitto 1
ES - Italia 1
JP - Giappone 1
LT - Lituania 1
NL - Olanda 1
PH - Filippine 1
PY - Paraguay 1
Totale 248
Città #
Singapore 37
Boardman 24
Dublin 15
Santa Clara 11
Parma 10
Ashburn 9
Beijing 8
Shanghai 8
Sassuolo 7
Cavriago 5
Bologna 4
Chiari 4
Helsinki 4
Kitzingen 4
Naples 4
Vienna 4
Collecchio 3
Milan 3
Chennai 2
Dietikon 2
Lisbon 2
New York 2
Torrile 2
Abidjan 1
Amsterdam 1
Ancona 1
Asunción 1
Cairo 1
Castelnuovo Rangone 1
Geislingen an der Steige 1
Grünwald 1
Hangzhou 1
Montecassiano 1
Munich 1
Princeton 1
Pune 1
Rome 1
S. Pietro 1
Soliera 1
Tokyo 1
Woodbridge 1
Totale 192
Nome #
Comparing the prognostic models to predict oncologic outcomes in patients with renal cell carcinoma: is AUC close enough to clinical practice? 27
Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic Score 26
Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario 21
Potential ROle of hypovitaminosis D in patiENts with cancer treated with immune ChEckpoint inhibitors (PROVIDENCE): a prospective observational study. 19
Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome? 19
Successful treatment with selpercatinib after pralsetinib-related pneumonitis and intracranial failure in a patient with RET-rearranged nonsmall cell lung cancer 17
Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study 15
Intersecting Blood Cytokines With Cholesterol Parameters to Profile Patients With Advanced Solid Tumors Receiving Immune Checkpoint Inhibitors 14
Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study) 14
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors 12
Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study 10
2125P Potential ROle of hypoVItaminosis D in patiENts with cancer treated with immune ChEckpoint inhibitors (PROVIDENCE): A prospective observational study 10
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors 9
Wolf in sheep's clothing or not? The pT1 LG dilemma 9
Differential impact of lipid profile according to neutrophil-to-lymphocyte ratio status in patients with advanced cancer treated with immunotherapy 8
Comparing a Part with the Whole: Beware of the Disparity of the Renal Cell Carcinoma Prognostic Models 8
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study 7
Prognostic Stratification by the Meet-URO Score in Real-World Older Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Cabozantinib: A Subanalysis of the Prospective ZEBRA Study (Meet-URO 9) 7
Pembrolizumab in patients with advanced upper tract urothelial carcinoma: a real-world study from ARON-2 project 5
The distinct prognostic impact of circulating lipid profile according to neutrophil to lymphocyte ratio in patients with advanced solid tumors treated with immune check point inhibitors. 5
Italian Registry on Rare Urological Tumors (Meet-URO-23): The First Analysis on Collecting Duct Carcinoma of the Kidney 5
Treatment of metastatic TFE3 microphthalmia transcription factor translocation renal cell carcinoma: a case report 4
Totale 271
Categoria #
all - tutte 1.889
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.889


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226 0 0 0 0 0 0 0 0 0 5 0 1
2022/202319 2 1 1 0 0 1 0 0 13 0 1 0
2023/2024119 0 24 9 2 5 10 12 1 12 8 6 30
2024/2025127 14 57 56 0 0 0 0 0 0 0 0 0
Totale 271